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The kinetic properties of the Na+/H+ exchanger in human platelets were investigated by direct measurements of pH, as detected with the fluorescent 
dye, BCECF. In acid-loaded cells, the antiporter displayed a hyperbolic dependence regarding external Na+ with an apparent K,,, of 38k4 mM 
@H, 7.2 at 25°C) whereas its pHidependent activation between 7.3 to 6.4 did not obey a Michaelian model. External acidification from 7.7 to 
6.5 decreased significantly the initial rate of Na+-dependent H+ efflux. The amiloride derivative, ethylisopropylamiloride blocked this exchanger 
and exerted a non-competitive inhibition with respect to Na+, (Ki= 17 nM). The cation selectivity of the external site of the antiporter was 
Na+ > Li+ > K+ and choline. These results indicate that the BCECF technique allows to evaluate the main features of the Nat/H+ exchanger in 
human platelets, which possesses kinetic properties imilar to those reported in other cell types. 
Na+/H+ exchanger; pHi; Human platelet 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The activity of the Na+ /H + exchanger is involved in 
various functions of human platelets, including the 
regulation of cytosolic pH and the control of platelet 
volume [ 1,2]. Determination of the kinetic properties of 
the exchanger is essential to define its physiological 
functions. Even though the antiporter has been propos- 
ed to be activated by pharmacological agents, including 
thrombin [3], ADP [4], the calcium ionophore A 23187 
[5], arachidonic acid and phorbol esters [6], the direct 
characterization of the exchanger has never been per- 
formed. Up to now, this exchanger has only been 
characterized using an indirect approach, based on 
volume changes that are associated with Na+ uptake in 
the presence of a weak acid [7]. Thus, the purpose of 
the present study was to examine the kinetic properties 
and the ionic specificity of the antiporter in human 
platelets by direct measurements of pHi with the aid of 
the pH-sensitive dye 2,7-biscarboxyethyl-5(6)-carboxy- 
fluorescein (BCECF). This dye offers several advant- 
ages such as a high sensitivity in the physiological pH 
range, high fluorescence intensity which limits the cell 
load and the capacity to enter the cell as its membrane 
permeant ester. Thus, BCECF is an appropriate dye to 
evaluate cytosolic pH. It has been successfully used to 
characterize the Na+ /H + exchanger in other cell lines 
[8-lo]. 
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2.1. Materials 
BCECF-AM (Molecular Probes, Eugene, OR) and ethyhsopropyl- 
amiloride (EIPA, a gift from Pharmitalia, Italy) were both dissolved 
in dimethylsulfoxide ultrapur (Fluka, Switzerland) at concentrations 
of 1 and 10 mM, respectively. Nigericin (Sigma) was dissolved in 
ethanol at a concentration of 1.38 mM. 
2.2. pHi determination 
Platelet-rich plasma (PRP) was obtained by centrifugation of 
freshly drawn human venous blood containing l/10 volume of 
anticoagulant (2.73% citric acid, 4.48% trisodium citrate and 2% 
glucose). The loading of platelets with BCECF was carried out as 
previously described [l 11. Briefly, PRP was incubated for 20 min at 
37°C with 2 PM BCECF-AM, then diluted two-fold with buffer A 
(145 mM NaCl, 5 mM KCl, 0.5 mM MgClz, 5 mM glucose and 10 mM 
Hepes, pH 7.2 at 25°C) or buffer B (buffer A where Naf has been 
substituted by N-methyl-D-glucamine (NMG+)) and centrifuged at 
270 x g for 10 min at 20°C. The pellet was then resuspended at a final 
concentration of 8-9 x 10’ cells/ml in either buffer A or B as desired, 
supplemented with 1 mM Ca(NOr)z. All measurements were perform- 
ed within 3 h after blood sampling. During that time, platelets were 
kept at room temperature. 
Aliquots of the platelet suspension (500 jd) were transferred to a 
quartz Suprazil micro-cuvette with optical pathways in excitation and 
emission of 1 and 5 mm, respectively, and thermostated at 25°C. 
Fluorescence intensities were recorded on a Spex Fluorolog CM1 11 
(Edison, New Jersey, USA) equipped with a 450 W Xenon lamp with 
wavelength settings of 503 and 532 nm, using 0.9 and 1.8 nm slits for 
excitation and emission, respectively. Under our experimental condi- 
tions, dye leakage did not exceed 10% per h at 25°C. pHi was deter- 
mined according to Rink at al. by lysing the cells with 0.1% Triton 
X-100 at the end of each experiment [9]. Calibration of the pHi versus 
fluorescence intensities was performed as previously described [8]. 
The platelets were suspended in a high K + -medium (115 mM KCI, 20 
mM NaCI, other constituents identical to buffer A, adjusted with 
KOH to pH ranging from 6.3 to 7.6 at 25’C) and treated with 
nigericin (2.76 PM), allowing the external pH (pH,) to set pHi. 
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Fig. 1. Activation of the Na+ /H+ exchanger by an intracellular 
acidification. Cytosolic acidification was achieved by the addition of 
1.38 pM nigericin (N). The apparent nigericin concentration was 
reduced by the addition of 2 mg/ml serum albumin (Alb). 20 mM 
NaCl were added either before the addition of 10 PM EIPA (A) or 
after the incubation for 10 minutes with 10 PM EIPA (B). This experi- 
ment is representative of 4 independent experiments. 
2.3. Determination of the buffer capafity of platelets and of the 
initial rate of Nu + -dependent H + efflux.. 
The determination of the cellular buffer capacity (0) was carried 
out by NHd+ titration. 10 mM NH&l was added to the cell suspen- 
sion during the fluorescence recordings and the buffer capacity was 
determined from the ratio of added base equivalents and the resulting 
pHi changes, according to the method of Roos and Boron 1121. 
To induce H + efflux, platelets were first acidified by suspension in 
buffer B to which 1.38 pM nigericin was added. When the decided pHi 
was reached, 2 mg/ml bovine serum albumin was added to reduce the 
apparent nigericin concentration. With this protocol, pHi remained 
constant until Na+ was added. The subsequent recovery of pHi was 
measured and shown to be strongly inhibited by the inhibitor of the 
Na+/H+ exchanger, EIPA (IO rM) (Fig. 1). The initial rate of pHi 
recovery was calculated as the change in fluorescence intensity as a 
function of time (i.e. during 15 s corresponding to a linear change). 
The initial rate of proton efflux in mmol .l- ’ I min - ’ was calculated 
by multiplying the initial rate of pHi recovery with the buffer capaci- 
ty. The results are expressed as mean * SE and n represents the 
number of independent experiments. 
3. RESULTS AND DISCUSSION 
Under control conditions, the mean pHi value 
averaged 7.36 + 0.04 (n = 7). The buffer capacity of the 
cells was 28.1 k 2.25 mmol~l-‘.pH units, -’ (n= 12) 
and remained constant between the pHi of 6.47 t- 0.08 
and 7.36 f 0.04 (30.20 s 4.80 and 26.61 t 2.61 
mmol*l-‘*pH units-‘, n = 5 and 7, respectively). 
?!b 
[No+], MO 
60 
~ 
40 
20 
0 4060 
V[Na+l, (M-l) 
Fig. 2. Control of H+ efflux by the extracellular Na+ concentration. 
Platelets suspended in buffer B at a concentration of 8-9 x 10 
cells/ml were acidified and then diluted IO-fold by buffers containing 
Na + concentrations ranging from 0 to 135 mM osmotically balanced 
with N-Methyl-D-Glutamine. (A) Dose-response curve of Na+ action 
on H+ efflux. (B) Lineweaver-Burk linearization of data. The line 
was fitted by the least squares method with a correlation coefficient 
of 0.963. Results are means of 5 experiments. 
To investigate the effect of external Na+ , the platelet 
cytosol was acidified to 6.4-6.5 and Na+ /H+ exchange 
initiated by platelet suspension in media containing 
various concentrations of Na +. The initial rate of H + 
efflux increased with the external Na+ concentration 
([Na+]*). This Na’-dependent activation of the ex- 
changer apparently followed simple Michaelis-Menten 
kinetics (Fig. 2A). This was confirmed by linearizing 
the data according to the Lineweaver-Burk method 
(Fig. 2B). Values fit a straight line which gave a max- 
imal rate of recovery with respect o Naeo of 65 + 10 
mmol~l-‘~min-l and indicated that half-maximal 
stimulation was attained with 38 +_ 4 mM [Na+10 
(n = 5). The michaelian kinetics suggest hat one Na+ 
ion and one H + are transported per cycle. The apparent 
affinity constant for Na + showed large variations from 
one cell type to another (3 to 90 mM) 17, 13-151. Using 
a similar approach, Livne et al. have determined in 
human platelets an apparent K,,, of 75 mM at pHi and 
pH, of 6.7 and 7.3, respectively 17). 
The cation selectivity of the external site for Na+ was 
investigated by measuring the ability of various 
monovalent cations to induce a H + extrusion. In the 
presence of 20 mM Na’ at pH, 7.2 and pH, 6.4-6.5, 
the initial rate of H ’ efflux was 21.74 k 1.78 
mmol.l-‘*min-‘(n=5). H+ efflux induced by 
equimolar concentrations of Li + and K ’ represented 
71 + 8% and 35 + 6% of the control value, respective- 
ly (15.73 + 2.41 and 7.87 -+ 1.43 mmoI.l-l*min-i, 
n = 5) whereas choline and NMG+ were totally ineffec- 
tive. Among these cations, only Li + promoted an 
EIPA-sensitive pHi recovery. This suggests that the 
K + -induced alkalinization was mediated by residual 
nigericin, as proposed by Grinstein et al. [ 131. A non- 
specific effect of the hyperosmolarity induced by the 
addition of these salts was ruled out by the observation 
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Fig. 3. Effect of intra- and extracellular pH on the Na+ -dependent H+ efflux. (A) Platelets suspended in buffer B at pH 7.2 were acidified at 
pHi ranging from 6.4 to 7.3. H+ efflux was initiated by addition of 20 mM NaCI. Means of H + efflux were plotted against he mean pHi at 0.2 
unit intervals. (B) Platelets were resuspended in buffer B adjusted to pH, ranging from 6.5 to 7.6 with KOH (1 N) and imme~ately acidified. 
Results represent means of 5 experiments. 
that 40 mM sucrose and 20 mM tetramethylammonium 
chloride did not significantly affect the fluorescence 
signal. 
The dependence of the Na + /H i exchanger on pHi 
was investigated at pH, 7.2. The rate of the 
Na + -dependent H + extrusion elicited by 20 mM Na + 
increased as the cytoplasmic pH decreased (Fig. 3A). 
Cytosolic acidification from 7.06 to 6.4 enhanced H’ 
efflux from0.5 to 19 mmol~l- ‘emin- I. This activation 
did not follow Michaelian kinetics, but is compatible 
with an aHosteric regulation by intracellular H + . This 
has been attributed to a kinetic control exerted by a 
modifier site besides the H+ transport site, first 
demonstrated in renal membrane vesicles 1161. This 
property has been later reported to be present in other 
cell types iI 0, I3]. This dependence of the exchanger ac- 
tivity on pHi thus underlines its major role in pHi 
homeostasis in platelets. 
To study the influence of external pH on the ex- 
changer activity, platelets were suspended in media ad- 
justed to various pHo. In contrast to the pHi effect, an 
external alkalinization promoted an activation of the 
exchanger with a maximum H+ efflux reached at 7.6 
(Fig. 3B). In our experimental conditions, the decrease 
of pH, from 7.7 to 6.5 was associated with an in- 
tracellular acidification from 6.69 to 6.05. Changes in 
pH, from 7.7 to 7.1 were associated with a pHi decrease 
from 6.69 _t 0.02 to 6.30 rt 0.01 (n =4). If the H + ef- 
flux were controlled only by pHi, the expected rates in- 
duced by such an intracellular acidification would have 
been 7.34 Z? 2.18 and 21.78 4 1.78 mmol~l-l~min-l 
(n = 5) (Fig. 3A). However, the experimental values dif- 
fered from the above data (27.82 + 0.71 and 13.79 f 
1.26 mmol~l-‘+min-‘, n = 4). If this difference is at- 
tributed to a pH, effect, the external acidification pro- 
moted an inhibition of H + efflux which markedly 
reduced the pHi-dependent H+ extrusion. These results 
suggest a mutual interaction between internal and exter- 
nal H + sites. Such a hypothesis has been suggested in 
rat brain synaptosomes, where it has been proposed 
that the binding of H + on the outer face of the ex- 
changer modified the interaction properties of the inter- 
nal H + binding site which controls the antiport activity 
1171. 
The pharmacological properties of the Na + /H + ex- 
changer in platelets was investigated in the presence of 
a derivative of amiloride, EIPA. The Dixon plot of the 
data exhibited a linear relationship between the in- 
hibitor concentration and the inverse of H + efflux in- 
duced by the addition of 20 or 50 mM Na+ (Fig. 4). The 
intercepting values on the x-y axis indicated that EIPA 
did not compete with Na+, since the apparent inhibi- 
tion constant (Ki) was not affected by an increase in ex- 
ternal Na+ concentration from 20 to 50 mM (18.47 + 
-3 -2 -1 0 1 2 3 4 5 6 
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Fig. 4. Inhibition of the Na+-dependent H+ efflux by EIPA. 
Platelets suspended in buffer B were incubated for IO min with EIPA 
(0 to 5x 10-a M) and then acidified. H+ efflux was initiated by the 
addition of 20 (0) or 50 mM NaCl (e). The representation of Dixon 
was used and lines were fitted by the least squares method with cor- 
relation coefficients of 0.961 and 0.975. Results are means of 4 ex- 
periments. 
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1.10 and 15.70 + 3.90 nM (n =4), respectively), 
whereas the maximal rate of H + extrusion was enhanc- 
ed from 20.44 + 1.57 to 38.8 2 4.07 mmol~l-‘+min-’ 
(n = 4). Our results suggest hat EIPA was a more po- 
tent inhibitor of platelet Na+ /H + exchange than 
amiloride (Ki = 8 PM) [7] and that its Ki is in agreement 
with those reported in other cell types [ 18,191. In addi- 
tion, EIPA interacted with a site on the transporter 
which was not affected by Na+O. This last observation 
is consistent with previous results reported in lym- 
phocytes with another 5-(iV,N disubstituted) amiloride 
analog: the (5N-methyl-N-isobutyl) amiloride (MIA) 
1201. 
In summary, we presented herein the direct 
characterization of the kinetic and pharmacological 
properties of the Na+ /H + exchanger in human 
platelets. Using the BCECF technique, we 
demonstrated that the properties of the antiporter and 
its cation selectivity were comparable to those reported 
in other ceil types and in platelets when investigated by 
an indirect approach. We demonstrate that EIPA is a 
potent inhibitor of the platelet exchanger and acts non- 
competitively with external Na+ . The present approach 
should allow a direct evaluation of the characteristics of 
the exchanger under platelet stimulation and its par- 
ticipation to the physiological and the pathological 
changes of cytosolic pII. 
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